• Home
  • Mutual Funds
  • WhiteOak Capital Pharma and Healthcare Fund Growth

Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹100 & Lump. ₹500

AUM (Fund size)

₹556 Cr

Lock In Period

N/A

Expense Ratio

2.35

Benchmark

BSE Healthcare Total Return

Exit Load

Nil

Summary

Latest details for WhiteOak Capital Pharma and Healthcare Fund Growth include a ₹14.231 NAV as of Apr 27,2026 and returns since inception of --%. Minimum investments start at SIP ₹100. The WhiteOak Capital Pharma and Healthcare Fund Growth AUM is ₹556 Cr, with a lock-in of N/A years, expense ratio of 2.35%, and benchmark BSE Healthcare Total Return. Exit load is - Nil. In the growth review for 1M Month/Year, the fund recorded 3.01% returns, against a category average of 0.76% and a category best of 29.81%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M3.010.7629.81
6M-1.581.0299.33
1Y6.594.51256.53
3Y0.0013.32337.82

Portfolio Analysis

  • Equity: 93.48%
  • Debt: 6.52%
  • Others
As on: 2026-03-31
View allocation % by

1. Sun Pharmaceutical Industries Limited12.35%
2. JB Chemicals & Pharmaceuticals Limited8.90%
3. Lupin Limited5.77%
4. Divi's Laboratories Limited5.31%
5. Laurus Labs Limited3.93%
6. Glenmark Pharmaceuticals Limited3.17%
7. Aurobindo Pharma Limited3.02%
8. Sai Life Sciences Limited2.77%
9. Acutaas Chemicals Limited2.61%
10. Corona Remedies Limited2.27%
11. IPCA Laboratories Limited2.17%
12. Ajanta Pharma Limited2.11%
13. Emcure Pharmaceuticals Limited1.89%
14. Neuland Laboratories Limited1.42%
15. Pfizer Limited1.35%
16. Strides Pharma Science Limited1.24%
17. AstraZeneca Pharma India Limited1.07%
18. Zydus Lifesciences Limited0.83%
19. Dr. Reddy's Laboratories Limited0.74%
20. Sudeep Pharma Limited0.67%
21. Supriya Lifescience Limited0.64%
22. Zota Health Care Limited0.55%
23. Aarti Pharmalabs Limited0.48%
24. Orchid Pharma Limited0.19%
25. Alkem Laboratories Limited0.15%

1. Apollo Hospitals Enterprise Limited4.24%
2. Fortis Healthcare Limited3.85%
3. Max Healthcare Institute Limited3.79%
4. Krishna Institute Of Medical Sciences Limited3.16%
5. Narayana Hrudayalaya Limited1.72%
6. Thyrocare Technologies Limited1.56%
7. Dr. Lal Path Labs Limited1.34%
8. Kovai Medical Center and Hospital Limited1.20%
9. Vijaya Diagnostic Centre Limited0.94%
10. Rainbow Childrens Medicare Limited0.80%

1. Aether Industries Limited1.38%
2. Tatva Chintan Pharma Chem Limited0.21%

1. Shaily Engineering Plastics Limited1.58%

1. Navin Fluorine International Limited1.41%

About Fund

WhiteOak Capital Pharma and Healthcare Fund Growth managed by WhiteOak Capital Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹556 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.35. Under the expert guidance of Ramesh Mantri ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Ramesh Mantri

Mr. Ramesh Mantri holds MBA, CFA and CA. His prior assignments include White Oak Capital Management LLP, Ashoka Capital Advisers, Smith Management-Mumbai Office and CRISIL.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
This FundMirae Asset Infrastructure Fund Growth0330.36 CR2.4
This FundQuant Teck Fund Growth0191.09 CR2.43
This FundWhiteOak Capital Pharma and Healthcare Fund Growth0556.42 CR2.35
This FundICICI Prudential PSU Equity Fund Growth01798.21 CR2.1
This FundNippon India Taiwan Equity Fund Growth3599.16 CR2.36
Fund Name1Y3Y
This FundMirae Asset Infrastructure Fund Growth00
This FundQuant Teck Fund Growth-20.79910
This FundWhiteOak Capital Pharma and Healthcare Fund Growth6.58640
This FundICICI Prudential PSU Equity Fund Growth10.6143109.3953
This FundNippon India Taiwan Equity Fund Growth251.6237319.983

FAQs

WhiteOak Capital Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of WhiteOak Capital Pharma and Healthcare Fund Growth is 2.35. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

WhiteOak Capital Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 3.01%
  • 6 Months : -1.58%
  • 1 Year : 6.59%
  • 3 Years : 0.00%
Returns of WhiteOak Capital Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 14.231 as on Apr 27,2026. Since inception, the return has been 0.00%.

You can invest in WhiteOak Capital Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of WhiteOak Capital Pharma and Healthcare Fund Growth is ₹556 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in WhiteOak Capital Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500